Alexza Pharmaceuticals, Inc. Reports 2012 Third Quarter Financial Results and Provides Business Update
Published: Nov 07, 2012
MOUNTAIN VIEW, Calif., Nov. 6, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) today reported financial results for the fiscal quarter ended September 30, 2012 and provided a business update. The net loss for the quarters ended September 30, 2012 and 2011, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $6.9 million and $13.4 million, respectively. The net loss for the nine-month periods ended September 30, 2012 and 2011 were $17.7 million and $30.8 million, respectively. At September 30, 2012, Alexza had consolidated cash, cash equivalents, marketable securities and restricted cash of $32.0 million.